Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Patient man - udflyerfan
1
Dec 06, 2007 04:57AM
2
Dec 06, 2007 05:00AM
7
Dec 06, 2007 05:44AM

Dec 06, 2007 06:35AM
  • 4 institutions own 0.0% of the 0.39 billion co

Reuters reports the number of common shares in the increments in the billions. That is Point 39 billion common shares outstanding.

I think new potential investors may not notice the decimal point placed immediately before the 39 and may think this small company is just like all the other OTC stocks...extremely dilluted.

I hope this doesn't scare people off.

2
Dec 06, 2007 07:37AM

Dec 06, 2007 01:44PM
Share
New Message
Please login to post a reply